top
Search terms
Results 223271 - 223280 of 223352 - ordered by :
Pages: 1 ... 22325 22326 22327 22328 22329 22330 22331 ... 22336
Escardio

In this regard, a recent trial of postconditioning in 1,234 patients undergoing PCI failed to reduce the composite outcome of death from any cause and hospitalization for heart failure. (4) In 2015, ...

Date : 27/05/2019
Escardio

Recently, chemotherapy was reported as a potential factor uncovering TTNtv effects.4 Also, peripartum changes can be a factor uncovering the underlying genetic mutation as TTNtv are prevalent in ...

Date : 27/05/2019
ESC365

The benefits of ivabradine in the management of angina pectoris and heart failure.

Date : 28/05/2018
Escardio

Editorial Office Managing Editor Federica Dalè, Brescia (Italy) Tel: +39 (0)30 338 4130 Email: ejhf.editorialoffice@wiley.com Consulting Scientific Editor Paola Luciolli (Italy) Email: ...

Date : 09/12/2014
Escardio

Opening hours Saturday 31 August - Tuesday 3 September 08:00-19:00 Wednesday 4 September: 08:00-13:00 What you can expect inside the Lounge Free printed copy of the latest 2019 ESC Pocket Guidelines ...

Date : 01/03/2019
ESC365

What do recent landmark, cardiovascular outcome trials evaluating PCSK9 inhibition in high risk patient populations teach us?

Date : 27/08/2018
ESC365

Dual antiplatelet therapy and PCI - Important controversies

Date : 26/08/2018
ESC365

Depression and anxiety during the first 12 months post-implant: a matched cohort study of patients with a subcutaneous implantable defibrillator and patients with a transvenous system

Date : 17/03/2019
ESC365

ACS pharmacotherapy studies in Circulation

Date : 28/08/2018
ESC365

Learnings from the latest PCSK9i results and profiles of patients who may benefit the most: post- ACS patients with elevated atherogenic lipid levels

Date : 27/08/2018